Exercise modulates the interaction between cognition and anxiety in humans.


Journal

Cognition & emotion
ISSN: 1464-0600
Titre abrégé: Cogn Emot
Pays: England
ID NLM: 8710375

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 24 7 2018
medline: 28 4 2020
entrez: 24 7 2018
Statut: ppublish

Résumé

Despite interest in exercise as a treatment for anxiety disorders the mechanism behind the anxiolytic effects of exercise is unclear. Two observations motivate the present work. First, engagement of attention control during increased working memory (WM) load can decrease anxiety. Second, exercise can improve attention control. Therefore, exercise could boost the anxiolytic effects of increased WM load via its strengthening of attention control. Anxiety was induced by threat of shock and was quantified with anxiety-potentiated startle (APS). Thirty-five healthy volunteers (19 male, age M = 26.11, SD  = 5.52) participated in two types of activity, exercise (biking at 60-70% of heart rate reserve) and control-activity (biking at 10-20% of heart rate reserve). After each activity, participants completed a WM task (n-back) at low- and high-load during safe and threat. Results were not consistent with the hypothesis: exercise vs. control-activity increased APS in high-load (p = .03). However, this increased APS was not accompanied with threat-induced impairment in WM performance (p = .37). Facilitation of both task-relevant stimulus processing and task-irrelevant threat processing, concurrent with prevention of threat interference on cognition, suggests that exercise increases cognitive ability. Future studies should explore how exercise affects the interplay of cognition and anxiety in patients with anxiety disorders.

Identifiants

pubmed: 30032703
doi: 10.1080/02699931.2018.1500445
pmc: PMC6344312
mid: NIHMS1000274
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

863-870

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK071013
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 MH002798-07
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA MH002798
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA MH002798-17
Pays : United States

Références

J Clin Exp Neuropsychol. 2002 Sep;24(6):781-91
pubmed: 12424652
Front Hum Neurosci. 2013 May 30;7:228
pubmed: 23750133
Ann Med Exp Biol Fenn. 1957;35(3):307-15
pubmed: 13470504
Dev Sci. 2009 Jul;12(4):F9-15
pubmed: 19635074
Psychophysiology. 2016 Nov;53(11):1660-1668
pubmed: 27434207
Ann Behav Med. 2015 Aug;49(4):542-56
pubmed: 25697132
Psychopathology. 2002 Mar-Jun;35(2-3):67-71
pubmed: 12145486
Mayo Clin Proc. 2015 Apr;90(4):450-60
pubmed: 25746399
Circulation. 2013 Aug 20;128(8):873-934
pubmed: 23877260
J Sport Exerc Psychol. 2007 Dec;29(6):783-91
pubmed: 18089904
Psychopharmacology (Berl). 2016 Oct;233(19-20):3565-74
pubmed: 27492789
Ann Noninvasive Electrocardiol. 2004 Jul;9(3):291-303
pubmed: 15245347
Int J Psychophysiol. 2003 Jun;48(3):307-14
pubmed: 12798990
Percept Mot Skills. 2017 Dec;124(6):1164-1193
pubmed: 28829227
PLoS One. 2014 Jun 09;9(6):e99222
pubmed: 24911975
Expert Rev Neurother. 2012 Aug;12(8):1011-22
pubmed: 23002943
Emotion. 2006 Feb;6(1):40-61
pubmed: 16637749
Front Neuroendocrinol. 2017 Jan;44:83-102
pubmed: 27956050
Sports Med. 2001;31(14):965-83
pubmed: 11735681
Med Sci Sports Exerc. 2009 Apr;41(4):927-34
pubmed: 19276839
Learn Mem. 2017 Aug 16;24(9):407-413
pubmed: 28814466
Neuropsychopharmacology. 2015 Mar 13;40(5):1064-71
pubmed: 25430779
Trends Cogn Sci. 2011 Jan;15(1):28-36
pubmed: 21146447
Psychon Bull Rev. 2013 Apr;20(2):228-42
pubmed: 23233157
Int J Sports Med. 1997 Apr;18(3):161-8
pubmed: 9187968
Pharmacol Biochem Behav. 1994 Jun;48(2):307-14
pubmed: 7916463
J Cogn Neurosci. 2010 Feb;22(2):248-62
pubmed: 19400679
Psychon Bull Rev. 2017 Aug;24(4):1282-1311
pubmed: 28108977
J Exerc Nutrition Biochem. 2017 Jun 30;21(2):1-8
pubmed: 28715880
Clin Neurophysiol. 2003 Sep;114(9):1557-79
pubmed: 12948786
Brain Res Bull. 1997;42(5):399-406
pubmed: 9092882
Psychophysiology. 2012 Jun;49(6):842-52
pubmed: 22332819
Nat Protoc. 2012 Feb 23;7(3):527-32
pubmed: 22362158
Psychopharmacology (Berl). 2003 Jun;167(4):411-7
pubmed: 12677354

Auteurs

Tiffany R Lago (TR)

a Section on the Neurobiology of Fear and Anxiety , National Institute of Mental Health , Bethesda , MD , USA.

Abigail Hsiung (A)

a Section on the Neurobiology of Fear and Anxiety , National Institute of Mental Health , Bethesda , MD , USA.

Brooks P Leitner (BP)

b Energy Metabolism Section, Diabetes, Endocrinology, and Obesity Branch , National Institute of Diabetes and Digestive and Kidney Diseases , Bethesda , MD , USA.

Courtney J Duckworth (CJ)

b Energy Metabolism Section, Diabetes, Endocrinology, and Obesity Branch , National Institute of Diabetes and Digestive and Kidney Diseases , Bethesda , MD , USA.

Nicholas L Balderston (NL)

a Section on the Neurobiology of Fear and Anxiety , National Institute of Mental Health , Bethesda , MD , USA.

Kong Y Chen (KY)

b Energy Metabolism Section, Diabetes, Endocrinology, and Obesity Branch , National Institute of Diabetes and Digestive and Kidney Diseases , Bethesda , MD , USA.

Christian Grillon (C)

a Section on the Neurobiology of Fear and Anxiety , National Institute of Mental Health , Bethesda , MD , USA.

Monique Ernst (M)

a Section on the Neurobiology of Fear and Anxiety , National Institute of Mental Health , Bethesda , MD , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH